Retrospective study on disparities in time-to-treatment by health insurance system in Chilean breast cancer patients

Estudios originales

Published on 10 de abril de 2025 | http://doi.org/10.5867/medwave.2025.03.3033

Retrospective study on disparities in time-to-treatment by health insurance system in Chilean breast cancer patients

Back to article Table 5

Hazard ratios for age and total treatment time, stratified by breast cancer stage.

Risk factor	Stage I (n = 141)		Stage II (n = 187)		Stage III (n = 61)
Risk factor	HR (95% CI)	p value	HR (95% CI)	p value	HR (95% CI)	p value
Age	0.95 (0.87 to 1.03)	0.22	1.03 (1.01 to 1.07)	0.02	1.03 (0.96 to 1.07)	0.21
Total treatment time^*	1.04 (1.01 to 1.08)	0.01	1 (0.98 to 1.02)	0.94	0.99 (0.95 to 1.02)	0.47

HR, hazard ratio. CI, confidence interval.

*From diagnosis to radiotherapy (weeks).

Source: Prepared by the authors.